HM
DAWN

HealthCor Management’s Day One Biopharmaceuticals DAWN Stock Holding History

HealthCor Management’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-103,717
Closed -$2.36M – 75
2021
Q2 		$2.36M Buy
+103,717
New +$2.16M 0.09% 60

Other funds holding DAWN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

HealthCor Management's DAWN Position: Q3 2021 in Review

HealthCor Management sold out of Day One Biopharmaceuticals (DAWN) in Q3 2021, closing a stake of 103,717 shares — an estimated $2.36M sold.

HealthCor Management first reported a position in DAWN in Q2 2021 and held it in 1 quarter. The position peaked at $2.36M in Q2 2021. 45 funds tracked by Wall St. Rank hold DAWN as of Q3 2021.

  • HealthCor Management reported no remaining Day One Biopharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • HealthCor Management sold 103,717 Day One Biopharmaceuticals shares in Q3 2021, an estimated $2.36M.
  • HealthCor Management first reported a position in Day One Biopharmaceuticals in Q2 2021 and held it in 1 quarter.
  • HealthCor Management's Day One Biopharmaceuticals position peaked at $2.36M in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q3 2021.

Based on HealthCor Management's 13F filing for Q3 2021, filed 15 Nov 2021.